Our Products - Sanotize

NORS^TM for COVID-19

SaNOtize is working diligently with Health Canada and the FDA to obtain approval for the emergency release of a preventative treatment for healthcare workers and high risk individuals exposed to SARS-CoV-2.

NORS2791 for Treatment of Acne

NORS2791 product candidate will be a topical formulation of NORS^TM for the treatment of acne, a chronic, inflammatory skin condition. This formulation will be delivered as a topical gel.

NORS4002 for Treatment of Sinusitis

The SaNOtize team believes that NORS^TM may be especially effective as a nasal lavage for treating sinusitis, regardless of infectious etiology. In vitro studies have shown the efficacy of NO and NO delivered through NORS^TM against many strains of bacteria, viruses and fungi associated with sinusitis.

NORS0791 for Treatment of Onychomycosis

NORS2791 product candidate will be a topical formulation of NORS^TM for the treatment of onychomycosis, a fungal infection of the toenail. For these patients, NORS^TM will be delivered via a specially designed bandage containing a NO releasing gel.

NORS1002 for Treatment and Prevention of the Cold & Flu

Our in-vitro studies indicate that NORS^TM may be effectively delivered as nasal spray to prevent the common cold and flu.

NORS6491 for Treatment of Athlete’s Foot

The SaNOtize team has completed in-vitro studies showing the ability of NORS^TM to eradicate common fungi associated with athlete’s foot.